Get startedLog in
    Picture of SynAct Pharma AB logo

    SYNACT — SynAct Pharma AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Synact Pharma Announces Outcome Of Directed Share Issues

    Picture of SynAct Pharma AB logoSynAct Pharma AB
    17/12/2024 10:01
    Dec 17 (Reuters) - SynAct Pharma AB  SYNACT.ST :
    * SYNACT PHARMA AB ANNOUNCES OUTCOME OF THE DIRECTED SHARE
ISSUES
    * SUBSCRIPTION PRICE PER SHARE IN DIRECTED ISSUES IS 8.65
SEK PER
SHARE
    * ALL SHARES HAVE TODAY BEEN SUBSCRIBED THROUGH SUBSCRIPTION
ON
SUBSCRIPTION LIST AT SHARE PRICE OF 8.65 SEK PER SHARE

Source text:  ID:nMFN5fvhcB 
Further company coverage:  SYNACT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on SynAct Pharma AB

    See all news